Table 3. Progression of esophageal lesions with positive ANO1 expression in two independent cohorts from endoscopy screening.
| Cohort | Initial examination | Initial diagnosis | Endpoint Time | Endpoint Result | Alteration |
|---|---|---|---|---|---|
| 1st | 2007 | ESCC | 2011 | Died of ESCC | Progressed |
| 1st | 2007 | ESCC | 2012 | Died of ESCC | Progressed |
| 1st | 2007 | ESCC | 2010 | Died of ESCC | Progressed |
| 1st | 2006 | CIS | 2006 | ESCC diagnosed | Progressed |
| 1st | 2007 | SD | 2012 | ESCC diagnosed | Progressed |
| 1st | 2005 | MD | 2009 | Intramucosal carcinoma | Progressed |
| 1st | 2007 | mD | 2012 | MD diagnosed | Progressed |
| 1st | 2005 | mD | 2012 | ES diagnosed | Regressed |
| 2nd | 2001 | CIS | 2005 | ESCC diagnosed | Progressed |
| 2nd | 1998 | SD | 2000 | ESCC diagnosed | Progressed |
| 2nd | 1996 | SD | 2011 | Died of ESCC | Progressed |
| 2nd | 2000 | SD | 2005 | SD diagnosed | Unchanged |
ES, esophagitis; mD, mild dysplasia; MD, moderate dysplasia; SD, severe hyperplasia; CIS, carcinoma in situ; ESCC, esophageal squamous cell carcinoma.